Literature DB >> 17081610

Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2.

Graeme O'Boyle1, John G Brain, John A Kirby, Simi Ali.   

Abstract

The chemokine receptor CCR2 binds four pro-inflammatory monocyte chemoattractant proteins, designated MCP1/CCL2, MCP2/CCL8, MCP3/CCL7 and MCP4/CCL13. This study demonstrates the important biology of this receptor during the response to the chemokine milieu. Competitive chemotaxis and calcium flux assays were performed utilising mixtures of chemokines to assess a hierarchal arrangement of chemokine prepotency; these demonstrated that the MCP2-CCR2 interaction is able to supersede signals generated by RANTES, another pro-inflammatory chemokine, or the homeostatic chemokine SDF1. These observations were validated using three physiologically relevant monocytic cell lines. Having identified the importance of CCR2, experiments were then performed to examine the signal transduction processes coupled to this receptor. G protein coupling was initially examined; Cholera toxin reduced the chemotactic response to MCP2 (p<0.001), whilst the response to the other MCP chemokines remained normal. The response to MCP2 was uniquely inhibited by elevated concentrations of cAMP and, unlike MCP1, 3 and 4 (p<0.05), MCP2 failed to inhibit adenylate cyclase. Expression of dominant negative H-ras demonstrated that each MCP chemokine required active ras in order to elicit ERK activation and a chemotactic response. Unlike MCP1, MCP2 failed to induce nuclear translocation of activated ERK1 or subsequent induction of c-Myc expression. Akt activation also showed ligand-specific differences, with MCP2 producing a delayed response compared to the other MCP chemokines. Together these data highlight the importance of CCR2 and suggest that it is a powerful tool for fine tuning the immune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081610     DOI: 10.1016/j.molimm.2006.09.033

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

1.  The yin and yang of chemokine receptor activation.

Authors:  Graeme O'Boyle
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  The expression of E-selectin and chemokines in the cultured human lymphatic endothelium with lipopolysaccharides.

Authors:  Yoshihiko Sawa; Eichi Tsuruga
Journal:  J Anat       Date:  2008-04-10       Impact factor: 2.610

3.  Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation.

Authors:  Graeme O'Boyle; Christopher R J Fox; Hannah R Walden; Joseph D P Willet; Emily R Mavin; Dominic W Hine; Jeremy M Palmer; Catriona E Barker; Christopher A Lamb; Simi Ali; John A Kirby
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

4.  Streptococcus pneumoniae aminopeptidase N regulates dendritic cells that attenuates type-2 airway inflammation in murine allergic asthma.

Authors:  Guangying Wu; Xuemei Zhang; Xu Chen; Jian Wang; Jing Yang; Ling Wang; Si Sun; Yuhong Qi; Hong Wang; Yibing Yin; Wenchun Xu
Journal:  Br J Pharmacol       Date:  2020-09-20       Impact factor: 8.739

5.  In vitro immunological effects of blocking CCR5 on T cells.

Authors:  Jing Yuan; Han-Yun Ren; Yong-Jin Shi; Wei Liu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

6.  Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.

Authors:  Jing Yuan; Han-yun Ren; Yong-jin Shi; Wei Liu
Journal:  Inflamm Res       Date:  2015-01-04       Impact factor: 4.575

7.  Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

Authors:  Graeme O'Boyle; Paul Mellor; John A Kirby; Simi Ali
Journal:  FASEB J       Date:  2009-08-10       Impact factor: 5.191

8.  CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.

Authors:  Hernan Roca; Zachary Varsos; Kenneth J Pienta
Journal:  J Biol Chem       Date:  2008-07-08       Impact factor: 5.157

9.  MAIDS resistance-associated gene expression patterns in secondary lymphoid organs.

Authors:  Suprawee Tepsuporn; Jedediah N Horwitt; George W Cobb; Sharon A Stranford
Journal:  Immunogenetics       Date:  2008-07-09       Impact factor: 2.846

10.  An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction.

Authors:  Merril Gersten; Mehrdad Alirezaei; Maria Cecilia Garibaldi Marcondes; Claudia Flynn; Timothy Ravasi; Trey Ideker; Howard S Fox
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.